229 related articles for article (PubMed ID: 17482306)
1. Insulin's 85th anniversary--An enduring medical miracle.
Heller S; Kozlovski P; Kurtzhals P
Diabetes Res Clin Pract; 2007 Nov; 78(2):149-58. PubMed ID: 17482306
[TBL] [Abstract][Full Text] [Related]
2. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery.
Klonoff DC
Pediatr Endocrinol Rev; 2003 Dec; 1(2):94-100. PubMed ID: 16437014
[TBL] [Abstract][Full Text] [Related]
3. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of soluble porcine and human insulin (Novo) using the artificial pancreas.
Mirouze J; Benghernaout O; Pham TC; Richard JL; Bringer J
Diabetes Care; 1983; 6 Suppl 1():40-2. PubMed ID: 6343037
[TBL] [Abstract][Full Text] [Related]
5. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
Baxter MA
Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
[TBL] [Abstract][Full Text] [Related]
6. Closed-loop insulin delivery - what lies between where we are and where we are going?
Steil GM; Rebrin K
Expert Opin Drug Deliv; 2005 Mar; 2(2):353-62. PubMed ID: 16296759
[TBL] [Abstract][Full Text] [Related]
7. Insulin pump therapy (continuous subcutaneous insulin infusion).
White RD
Prim Care; 2007 Dec; 34(4):845-71, vii. PubMed ID: 18061820
[TBL] [Abstract][Full Text] [Related]
8. How technology has changed diabetes management and what it has failed to achieve.
Ratheau L; Jeandidier N; Moreau F; Sigrist S; Pinget M
Diabetes Metab; 2011 Dec; 37 Suppl 4():S57-64. PubMed ID: 22208712
[TBL] [Abstract][Full Text] [Related]
9. Recent approaches in insulin delivery.
Trehan A; Ali A
Drug Dev Ind Pharm; 1998 Jul; 24(7):589-97. PubMed ID: 9876502
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety.
Rolla A
Am J Med; 2008 Jun; 121(6 Suppl):S9-S19. PubMed ID: 18514090
[TBL] [Abstract][Full Text] [Related]
11. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
[TBL] [Abstract][Full Text] [Related]
12. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2007 Jul; 23(5):348-55. PubMed ID: 17216593
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of porcine and human regular insulins using an artificial pancreas].
Mirouze J; Benghernaout O; Pham TC; Richard JL; Bringer J; Monnier L
Nouv Presse Med; 1982 Nov; 11(45):3331-3. PubMed ID: 6760120
[TBL] [Abstract][Full Text] [Related]
14. [Insulin--its past, present and future].
Grujić M; Hrisafović Z; Kulenović I
Med Arh; 1989; 43(1):45-50. PubMed ID: 2696853
[TBL] [Abstract][Full Text] [Related]
15. Chemically controlled closed-loop insulin delivery.
Ravaine V; Ancla C; Catargi B
J Control Release; 2008 Nov; 132(1):2-11. PubMed ID: 18782593
[TBL] [Abstract][Full Text] [Related]
16. [Update on new insulins].
Tapia Ceballos L
An Pediatr (Barc); 2009 Jan; 70(1):65-71. PubMed ID: 19174123
[TBL] [Abstract][Full Text] [Related]
17. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control.
Radermecker RP; Renard E; Scheen AJ
Diabetes Metab Res Rev; 2009 Sep; 25(6):491-501. PubMed ID: 19496088
[TBL] [Abstract][Full Text] [Related]
18. Inhaled insulin--does it become reality?
Siekmeier R; Scheuch G
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
[TBL] [Abstract][Full Text] [Related]
19. Closing the loop.
Dassau E; Atlas E; Phillip M
Int J Clin Pract Suppl; 2011 Feb; (170):20-5. PubMed ID: 21323809
[TBL] [Abstract][Full Text] [Related]
20. Refining basal insulin therapy: what have we learned in the age of analogues?
Devries JH; Nattrass M; Pieber TR
Diabetes Metab Res Rev; 2007 Sep; 23(6):441-54. PubMed ID: 17668418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
